(19)

(11)

EP 3 615 061 A1

(12)

(43) Date of publication: 04.03.2020 Bulletin 2020/10 (21) Application number: 18724619.4 (22) Date of filing: 27.04.2018

(51) International Patent Classification (IPC):  A61K 39/25(2006.01) A61K 39/12(2006.01) A61K 39/00(2006.01) C07K 14/04(2006.01) A61K 39/39(2006.01) (86) International application number: PCT/IB2018/052937 (87) International publication number: WO 2018/198085 (01.11.2018 Gazette 2018/44)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 28.04.2017 GB 201706798 15.05.2017 GB 201707785 02.10.2017 US 201762566861 P (71) Applicant: GlaxoSmithKline Biologicals S.A. 1330 Rixensart (BE)	(72) Inventor: OOSTVOGELS, Cornelia 1300 Wavre (BE) (74) Representative: Johnston, Caroline Louise  GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS Brentford, Middlesex TW8 9GS (GB)